Table 4 Comparison between +ve HCV patients and −ve HCV patients (surgical history, family history, blood transfusion history, type of IBD, and disease activity
HCV Ab | p-value | |||||
+ve | −ve | |||||
No. | % | No. | % | |||
Surgery-related to IBD | 2 | 16.7% | 10 | 83.3% | 0.043 | |
Surgery unrelated to IBD | 1 | 2.3% | 42 | 97.7% | 1 | |
Family history of hepatitis | 3 | 3.4% | 84 | 96.6% | 1 | |
Blood transfusion history | 4 | 10.3% | 35 | 89.7% | 0.011 | |
HCV Ab | p-value | |||||
+ve | −ve | |||||
No. | % | No. | % | |||
Subtypes | UC | 4 | 3.7% | 103 | 96.3% | 0.502 |
CD | 0 | 0.0% | 37 | 100.0% | ||
IBD-U | 1 | 4.8% | 20 | 95.2% | ||
PCDAI (IBD activity) | Severe | 0 | 0.0% | 1 | 100.0% | 0.001 |
Moderate | 1 | 33.3% | 2 | 76.7%% | ||
Clinical remission | 0 | 0.0% | 42 | 100.0% | ||
PUCAI (IBD activity) | Severe | 0 | 0.0% | 2 | 100.0% | 0.102 |
Moderate | 3 | 11.1% | 24 | 88..9% | ||
Clinical remission | 1 | 1.1% | 89 | 98.9% | ||